PRISM BioLab > ニュース > E7386, a selective inhibitor of the interaction between β-catenin and CBP, exerts antitumor activity in tumor models with activated canonical wnt signaling

E7386, a selective inhibitor of the interaction between β-catenin and CBP, exerts antitumor activity in tumor models with activated canonical wnt signaling

Published on: 9月 8, 2021

Japanese

ニュース

PRISMでは、サイエンスの議論が活発に行われています。あなたも参加してみませんか？